Sunrest Lifescience (NSE:SUNREST) Accounts Payable: ₹210.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUNREST Sunrest Lifescience Ltd NSE:SUNREST
41 GF Score
Price ₹35.00
! 5 Warning Signs
View Full Analysis

What is Sunrest Lifescience Accounts Payable?

Sunrest Lifescience NSE:SUNREST 41 Accounts Payable is ₹210.2 Mil as of Mar. 2026. GuruFocus rates NSE:SUNREST with a GF Score™ of 41/100. The stock has 5 warning signs investors should review.

Sunrest Lifescience's Accounts Payable for the quarter that ended in Mar. 2026 was ₹210.2 Mil.

Sunrest Lifescience's quarterly Accounts Payable increased from Sep. 2024 (₹60.5 Mil) to Mar. 2025 (₹229.3 Mil) but then declined from Mar. 2025 (₹229.3 Mil) to Mar. 2026 (₹210.2 Mil).

Sunrest Lifescience's annual Accounts Payable increased from Mar. 2024 (₹38.0 Mil) to Mar. 2025 (₹229.3 Mil) but then declined from Mar. 2025 (₹229.3 Mil) to Mar. 2026 (₹210.2 Mil).

Sunrest Lifescience Accounts Payable Related Terms

Sunrest Lifescience Accounts Payable Historical Data

* Premium members only.

The historical data trend for Sunrest Lifescience's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunrest Lifescience Accounts Payable Chart

Sunrest Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial 79.33 86.18 37.96 229.34 210.21

Sunrest Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only 0.00 37.96 60.52 229.34 210.21
NSE:SUNREST
41GF Score
Sunrest Lifescience Ltd NSE:SUNREST
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunrest Lifescience Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹210.2 Mil mean?
Sunrest Lifescience (NSE:SUNREST) has a Accounts Payable of ₹210.2 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Sunrest Lifescience and its competitors.
Is Sunrest Lifescience's Accounts Payable too high?
Sunrest Lifescience's current Accounts Payable is ₹210.2 Mil. Overall, Sunrest Lifescience has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's Accounts Payable compare to competitors?
Sunrest Lifescience's Accounts Payable of ₹210.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Healthcare Providers & Services company?
A good Accounts Payable depends on the Healthcare Providers & Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Sunrest Lifescience and its competitors. Sunrest Lifescience's current Accounts Payable is ₹210.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current Accounts Payable of ₹210.2 Mil. The current Accounts Payable is ₹210.2 Mil. Sunrest Lifescience's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current Accounts Payable is ₹210.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunrest Lifescience Business Description

Address YMCA Club, Near SG Highway, D-608 West Gate, Near Brooklin Tower, Makarba, Jivraj Park, Ahmedabad, GJ, IND, 380051
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
41GF Score

Get the complete analysis for NSE:SUNREST

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹35.00
Price